Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NR2E3 loss disrupts photoreceptor cell maturation and fate in human organoid models of retinal development
Nathaniel K. Mullin, … , Edwin M. Stone, Budd A. Tucker
Nathaniel K. Mullin, … , Edwin M. Stone, Budd A. Tucker
Published April 23, 2024
Citation Information: J Clin Invest. 2024;134(11):e173892. https://doi.org/10.1172/JCI173892.
View: Text | PDF
Research Article Development Ophthalmology

NR2E3 loss disrupts photoreceptor cell maturation and fate in human organoid models of retinal development

  • Text
  • PDF
Abstract

While dysfunction and death of light-detecting photoreceptor cells underlie most inherited retinal dystrophies, knowledge of the species-specific details of human rod and cone photoreceptor cell development remains limited. Here, we generated retinal organoids carrying retinal disease–causing variants in NR2E3, as well as isogenic and unrelated controls. Organoids were sampled using single-cell RNA sequencing (scRNA-Seq) across the developmental window encompassing photoreceptor specification, emergence, and maturation. Using scRNA-Seq data, we reconstruct the rod photoreceptor developmental lineage and identify a branch point unique to the disease state. We show that the rod-specific transcription factor NR2E3 is required for the proper expression of genes involved in phototransduction, including rhodopsin, which is absent in divergent rods. NR2E3-null rods additionally misexpress several cone-specific phototransduction genes. Using joint multimodal single-cell sequencing, we further identify putative regulatory sites where rod-specific factors act to steer photoreceptor cell development. Finally, we show that rod-committed photoreceptor cells form and persist throughout life in a patient with NR2E3-associated disease. Importantly, these findings are strikingly different from those observed in Nr2e3 rodent models. Together, these data provide a road map of human photoreceptor development and leverage patient induced pluripotent stem cells to define the specific roles of rod transcription factors in photoreceptor cell emergence and maturation in health and disease.

Authors

Nathaniel K. Mullin, Laura R. Bohrer, Andrew P. Voigt, Lola P. Lozano, Allison T. Wright, Vera L. Bonilha, Robert F. Mullins, Edwin M. Stone, Budd A. Tucker

×

Figure 7

Divergent rod fate in the context of ESCS.

Options: View larger image (or click on image) Download as PowerPoint
Divergent rod fate in the context of ESCS.
(A and B) D40–D260 data from ...
(A and B) D40–D260 data from the photoreceptor lineage of the current study integrated with the same cell types from Kallman et al. (31). Cells are shown split by study and projected in 2D space using UMAP embeddings. Divergent rods are colored lavender, and NRL-null cods are colored blue. (C and D) Differential expression analysis between pathological and normal rods from each study. Genes in yellow are significantly dysregulated in both NRL- and NR2E3-null cells compared with control rods. Genes in lavender (C) are dysregulated exclusively in divergent rods. Genes in blue (D) are dysregulated exclusively in NRL-null cods. (E–G) D260 retinal organoids from the current study stained for S-opsin. NR2E3-null organoids display a modest increase in the proportion of S-opsin–expressing cells. (H and I) Between D160 and D260 the rod proportion of NR2E3-null organoids decreases while the cone proportion increases. The opposite trend is observed in controls. (J) Staining of control postmortem donor retina shows rare short-wavelength cones (S-opsin), and colocalization of rhodopsin and GNAT1 in rods. (K–N) Cropped image from J showing S-cone (black arrowheads) and rods (white arrowheads). (O) In an NR2E3 disease donor retina, no rhodopsin staining is observed, and colocalization of S-opsin and GNAT1 is present. (P–S) Cropped image from O showing photoreceptor coexpressing S-opsin and GNAT1 (white arrowheads). Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts